North America Arrythmia Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (ECG Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telemetry, and Others), Application (Bradycardia, Tachycardia, Atrial Fibrillation, Ventricular Fibrillation, Premature Contraction, and Others), and End User (Hospitals and Clinics, Ambulatory Centers, Diagnostic Centers, and Others)
Market Introduction
The North America arrhythmia monitoring devices market is divided into the US, Canada, and Mexico. North America is likely to capture significant share of the global market in 2021. The US is the largest market for Arrhythmia Monitoring Devices at a global level. The market's growth is attributed to increasing product development and growing government support to enhance heart treatment. In addition, the growing incidences of heart disease and its risk have led to the growth of the market indirectly. Cardiac arrhythmias, or irregular heart rhythms, can cause chest pain and fainting, and may lead to sudden cardiac death or stroke. According to the American Heart Association, 835,000 Americans are discharged from hospital care with cardiac arrhythmia diagnoses each year.1 More than 2.2 million Americans experience atrial fibrillation each year, a type of cardiac arrhythmia that is associated with an increased risk for stroke. According to the Centers for Disease Control and Prevention (CDC), in the United States, Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups. As per the given facts, in every 36 seconds, one person dies from cardiovascular disease, and 1 in every 4 deaths is because of heart disease, i.e., approximately 655,000 Americans die from heart disease each year. Due to the growing risk of heart disease, various initiatives are taking place. For instance, to prevent, manage, and reduce the risk factors associated with heart disease and stroke, CDC’s Division for Heart Disease and Stroke Prevention (DHDSP) supports state, local, and tribal. Along with DHDSP, the Division of Diabetes Translation also supports all 50 states and the District of Columbia to address the serious national health problems of diabetes, heart disease, and stroke.
COVID-19 virus outbreak was first observed in December 2019 in Wuhan (China), and it has spread to ~100 countries across the world, with the World Health Organization (WHO) stating it as a public health emergency. The global impacts of COVID-19 are being felt across several markets. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. North America witnessed growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases reached to 34,434,803 million with 617,875 deaths reported in the United States as of 23rd June 2021. Similar impact was noticed in Mexico and Canada. As a result, healthcare systems are overburdened, and the delivery of medical care to all patients has become a challenge in the region. Moreover, sudden surge in number of infections led to shortage of emergency health supplies such as ventilators, beds, and oxygen cylinders. In order to manage the outbreak, government took preventive measures including total lockdowns and social distancing policies. In addition, medical device industry is also facing negative impact of this pandemic. As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Many companies offering products for cardiac monitoring have their business operations in the United states and business are adversely being affected by the effects of a widespread outbreak of COVID-19. This has disrupted and restricted company’s ability to distribute products, as well as temporary closures of our facilities or the facilities of our suppliers or customers. Moreover, market players also witnessed disruption in their business operations since March 2020, as US healthcare authorities framed policies about elective cardiac surgeries. Also, to free-up limited space for people being treated for the virus, hospitals have postponed, or cancelled. However, demand for vital sign monitoring devices in the region had substantial impact on the adoption of ECG Monitors. Though, there was disruption in distribution, demand for such products had marginal negative impact on the North America arrhythmia monitoring devices market.
Get more information on this report :
Market Overview and Dynamics
The arrythmia monitoring devices market in North America is expected to grow from US$ 2,454.28 million in 2021 to US$ 3,910.84 million by 2028; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028. Market consolidations; Changes or shift in technology-related trends encourage players to develop innovative devices. Recent developments in HIPPA-compliant technology have enabled secured data transmission throughout the monitoring period without delays. Emerging technologies are providing effective alternatives for traditional Holter monitors that create alerts for patients with a high risk of cardiac arrhythmia. Hence, continuous remote monitoring capabilities of these devices facilitating long-term, uninterrupted cardiac rhythm management are adding to their popularity. The mobile cardiac telemetry (MCT) system is an innovative product that assist in monitoring heart conditions of cardiac patients. Patients carry the tiny sensor and monitor throughout the day, and whenever, a cardiac event occurs, MCT sends the data to a central system for analysis and reaction. The system generates a report and shares it with the patient's physician, along with graphs and trends, for further actions. The abilities of MCT systems to analyze every heartbeat with little interference to the patient's normal days and to initiate an immediate emergency response as needed make them one of the most attractive choices cardiac monitoring. This is bolstering the growth of the arrythmia monitoring devices market.
Key Market Segments
In terms of type, the holter monitors segment accounted for the largest share of the North America arrythmia monitoring devices market in 2020. In terms of application, the atrial fibrillation segment held a larger market share of the arrythmia monitoring devices market in 2020. Further, the hospitals and clinics segment held a larger share of the market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on arrythmia monitoring devices market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; Koninklijke Philips N.V.; General Electric Company; Hill-Rom Holding Inc.; Medtronic; Biotronik, Inc.; AiveCor, Inc; ACS Diagnostics; Medicalgorithmics; OSI Systems, Inc; among others.
Reasons to buy report
- To understand the North America arrythmia monitoring devices market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America arrythmia monitoring devices market
- Efficiently plan M&A and partnership deals in North America arrythmia monitoring devices market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America arrythmia monitoring devices market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
NORTH AMERICA ARRYTHMIA MONITORING DEVICES MARKETSEGMENTATION
North America Arrythmia Monitoring Devices Market – By Type
- ECG Monitors
- Implantable Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
- Others
North America Arrythmia Monitoring Devices Market – By Application
- Bradycardia
- Tachycardia
- Atrial Fibrillation
- Ventricular Fibrillation
- Premature Contraction
- Others
North America Arrythmia Monitoring Devices Market – By End User
- Hospitals and Clinics
- Ambulatory Centers
- Diagnostic Centers
- Others
North America Arrythmia Monitoring Devices Market, by Country
- US
- Canada
- Mexico
North America Arrythmia Monitoring Devices Market -Companies Mentioned
- Abbott
- ACS Diagnostics
- AiveCor, Inc
- Biotronik, Inc.
- General Electric Company
- Hill-Rom Holding Inc.
- Koninklijke Philips N.V.
- Medicalgorithmics
- Medtronic
- OSI Systems, Inc
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Arrhythmia Monitoring Devices Market – By Type
1.3.2 North America Arrhythmia Monitoring Devices Market – By Application
1.3.3 North America Arrhythmia Monitoring Devices Market – By End User
1.3.4 North America Arrhythmia Monitoring Devices Market– By Country
2. North America Arrhythmia Monitoring Devices Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Arrhythmia Monitoring Devices Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts Opinion
5. North America Arrhythmia Monitoring Devices Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Incidence of Cardiovascular Diseases
5.1.2 Surge in Geriatric Population Base
5.2 Market Restraints
5.2.1 High Cost of Products and Procedures
5.3 Future Trends
5.3.1 Market Consolidations
5.4 Impact Analysis
6. Arrhythmia Monitoring Devices Market– North America Analysis
6.1 North America Arrhythmia Monitoring Devices Market Revenue Forecast and Analysis
7. North America Arrhythmia Monitoring Devices Market Analysis – By Type
7.1 Overview
7.2 North America Arrhythmia Monitoring Devices Market Revenue Share, by Type (2021 and 2028)
7.3 ECG Monitors
7.3.1 Overview
7.3.2 ECG monitors: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Implantable Monitors
7.4.1 Overview
7.4.2 Implantable Cardiac Monitor: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Holter Monitors
7.5.1 Overview
7.5.2 Holter Monitors: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Mobile Cardiac Telemetry
7.6.1 Overview
7.6.2 Mobile Cardiac Telemetry: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Arrhythmia Monitoring Devices Market Analysis – By Application
8.1 Overview
8.2 North America Arrhythmia Monitoring Devices Market, by Application 2021 & 2028 (%)
8.3 Bradycardia
8.3.1 Overview
8.3.2 Bradycardia: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Tachycardia
8.4.1 Overview
8.4.2 Tachycardia: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Atrial Fibrillation
8.5.1 Overview
8.5.2 Atrial Fibrillation: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Ventricular Fibrillation
8.6.1 Overview
8.6.2 Ventricular Fibrillation: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Premature Contraction
8.7.1 Overview
8.7.2 Premature contractions: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Arrhythmia Monitoring Devices Market Analysis – By End User
9.1 Overview
9.2 North America Arrhythmia Monitoring Devices Market Revenue Share, by End User (2021 and 2028)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Centers
9.4.1 Overview
9.4.2 Ambulatory Centers: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Centers
9.5.1 Overview
9.5.2 Diagnostic Centers: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Arrhythmia Monitoring Devices Market – Country Analysis
10.1 North America: Arrhythmia Monitoring Devices Market
10.1.1 Overview
10.1.3 North America Arrhythmia Monitoring Devices Market, by Type – Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Arrhythmia Monitoring Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Arrhythmia Monitoring Devices Market, by Technology – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Arrhythmia Monitoring Devices Market, by Country, 2021 & 2028 (%)
10.1.7 US: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 US: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 US Arrhythmia Monitoring Devices Market, by Type – Revenue and Forecast to 2028 (USD Million)
10.1.7.3 US Arrhythmia Monitoring Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.7.4 US Arrhythmia Monitoring Devices Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.8 Canada: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Canada: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Canada Arrhythmia Monitoring Devices Market, by Type – Revenue and Forecast to 2028 (USD Million)
10.1.8.3 Canada Arrhythmia Monitoring Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.8.4 Canada Arrhythmia Monitoring Devices Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.9 Mexico: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.1 Mexico: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.2 Mexico Arrhythmia Monitoring Devices Market, by Type – Revenue and Forecast to 2028 (USD Million)
10.1.9.3 Mexico Arrhythmia Monitoring Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.9.4 Mexico Arrhythmia Monitoring Devices Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Arrhythmia Monitoring Devices Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Arrhythmia Monitoring Devices Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Koninklijke Philips N.V.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 General Electric Company
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Hill-Rom Holding Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medtronic
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Biotronik, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 AliveCor, Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ACS Diagnostics
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medicalgorithmics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 OSI Systems, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of TermsLIST OF TABLES
Table 1. North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Arrhythmia Monitoring Devices Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Arrhythmia Monitoring Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Arrhythmia Monitoring Devices Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 5. US Arrhythmia Monitoring Devices Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. US Arrhythmia Monitoring Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. US Arrhythmia Monitoring Devices Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Arrhythmia Monitoring Devices Market, by Type -Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Arrhythmia Monitoring Devices Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Arrhythmia Monitoring Devices Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Arrhythmia Monitoring Devices Market, by Type -Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Arrhythmia Monitoring Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Arrhythmia Monitoring Devices Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14. Organic Developments Done by Companies
Table 15. Inorganic Developments Done by Companies
Table 16. Glossary of Terms, Arrhythmia Monitoring Devices MarketLIST OF FIGURES
Figure 1. North America Arrhythmia Monitoring Devices Market Segmentation
Figure 2. North America Arrhythmia Monitoring Devices Segmentation, By Country
Figure 3. North America Arrhythmia Monitoring Devices Market Overview
Figure 4. Holter Monitors Held the Largest Share of the Type Segment in North America Arrhythmia Monitoring Devices Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Arrhythmia Monitoring Devices Market: Impact Analysis of Drivers and Restraints
Figure 8. North America Arrhythmia Monitoring Devices Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Arrhythmia Monitoring Devices Market Revenue Share, by Type (2021 and 2028)
Figure 10. ECG Monitors: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Implantable Cardiac Monitor: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Holter Monitors: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Mobile Cardiac Telemetry: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Arrhythmia Monitoring Devices Market, by Application 2021 & 2028 (%)
Figure 16. Bradycardia: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Tachycardia: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Atrial Fibrillation: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Ventricular Fibrillation: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Premature contractions: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Arrhythmia Monitoring Devices Market Revenue Share, by End User (2021 and 2028)
Figure 23. Hospitals & Clinics: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Ambulatory Centers: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Diagnostic Centers: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: North America Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Arrhythmia Monitoring Devices Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. North America: Arrhythmia Monitoring Devices Market, by Country, 2021 & 2028 (%)
Figure 29. US: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Canada: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Mexico: Arrhythmia Monitoring Devices Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in North American Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Abbott
- ACS Diagnostics
- AiveCor, Inc
- Biotronik, Inc.
- General Electric Company
- Hill-Rom Holding Inc.
- Koninklijke Philips N.V.
- Medicalgorithmics
- Medtronic
- OSI Systems, Inc
- To understand the North America arrythmia monitoring devices market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America arrythmia monitoring devices market
- Efficiently plan M&A and partnership deals in North America arrythmia monitoring devices market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America arrythmia monitoring devices market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region